Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
V
Vazvaei-Smith, Faye
Merck & Co., Inc.
(
T1530-02-09
)
False Positive or Not? – Assessing Potential Interference of Soluble Target to ADA Detection for a Clinical Stage Program
Faye Vazvaei-Smith
Favorite
Venet, Joris
Gyros Protein Technologies
(
T1330-02-11
)
Oligonucleotide Dual Hybridization Assay Using Offline Pre-incubation followed by an Automated Microfluidic Method
Joris Venet
Favorite
Verch, Thorsten
Merck & Co., Inc.
(
W1330-02-11
)
One Drop of Blood, Multiple Sets of Data --- Establishing A Common Protocol for Serotype Specific IGG Concentration Testing Using Mitra® VAMS Dry Blood Samples to Support Vaccine Clinical Studies
Thorsten Verch
Favorite
Villafeurte-Vega, Rosendo
University of Michigan
(
T1430-02-10
)
A Novel In Vitro Serum Stability Assay for Antibody Therapeutics Incorporating Internal Standards
Rosendo Villafeurte-Vega
Favorite
Villamagna, Ian
Phosphorex
(
W1330-02-09
)
Using Cryo-TEM to Characterize Structural Details of LNPs during Manufacturing
Ian Villamagna
Favorite
Vlasak, Josef
Merck & Co., Inc.
(
T1030-02-11
)
The Importance of Orthogonal Methods for the Determination of the Size Distribution of Lipid Nanoparticles
Josef Vlasak
Favorite
Vomero, Maria
NeuroOne
(
W1430-01-04
)
Innovative Device for Concomitant Therapeutic Compound Delivery into the Brain and Neural Recordings - Feasibility Bench and In Vivo Studies
Maria Vomero
Favorite
